HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N(beta)- fumarylcarboxyamido- 2,3- diaminopropionic acid (FCDP)

structure given in first source

Also Known As:

FCDP; N beta-furmarylcarboxyamido-2,3-diaminopropionic acid; L-Alanine, 3-((4-amino-1,4-dioxo-2-butenyl)amino)-, (E)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Dicarboxylic Acids: 108
      - Fumarates: 813
        N(beta)-fumarylcarboxyamido-2,3-diaminopropionic acid: 2
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Alanine: 4133
    - beta-Alanine: 172
      - N(beta)-fumarylcarboxyamido-2,3-diaminopropionic acid: 2

Related Diseases

1.	Infections 01/01/2012 - "Par contre, l’expression du FCDP-AA n’était stimulée qu’après une infection par le CMVH. " 12/01/2023 - "Here, we review the potential of FC-derived products (FCDP) in slowing down the progression of cancers, acute/chronic inflammation-related conditions, infections, metabolic disorders, toxicities, neurological and neuromuscular diseases, gastrointestinal disorders, vascular diseases, and skin-stressing conditions, as well as, in boosting normal healthy functions of the endocrine, immune, metabolic, and nervous systems. "
2.	Coinfection 01/01/2012 - "Les chercheurs ont mesuré la production d’interleukine (IL)-6, d’IL-8, du facteur de croissance basique des fibroblastes (FCbF), du facteur de croissance dérivé des plaquettes (FCDP) et de la protéine RANTES régulée à l’activation, exprimée par les lymphocytes T normaux et sécrétée en présence de co-infection des cellules des muscles lisses de l’aorte (CMLA). "
3.	Vascular Diseases (Vascular Disease) 12/01/2023 - "Here, we review the potential of FC-derived products (FCDP) in slowing down the progression of cancers, acute/chronic inflammation-related conditions, infections, metabolic disorders, toxicities, neurological and neuromuscular diseases, gastrointestinal disorders, vascular diseases, and skin-stressing conditions, as well as, in boosting normal healthy functions of the endocrine, immune, metabolic, and nervous systems. "
4.	Neuromuscular Diseases (Neuromuscular Disease) 12/01/2023 - "Here, we review the potential of FC-derived products (FCDP) in slowing down the progression of cancers, acute/chronic inflammation-related conditions, infections, metabolic disorders, toxicities, neurological and neuromuscular diseases, gastrointestinal disorders, vascular diseases, and skin-stressing conditions, as well as, in boosting normal healthy functions of the endocrine, immune, metabolic, and nervous systems. "
5.	Neoplasms (Cancer) 12/01/2023 - "Here, we review the potential of FC-derived products (FCDP) in slowing down the progression of cancers, acute/chronic inflammation-related conditions, infections, metabolic disorders, toxicities, neurological and neuromuscular diseases, gastrointestinal disorders, vascular diseases, and skin-stressing conditions, as well as, in boosting normal healthy functions of the endocrine, immune, metabolic, and nervous systems. "

Related Drugs and Biologics

1.	Chemokine CCL5
2.	chlormadinol acetate (CMLA)